Articles |
the Scripps Research Institute, Department of Immunology (W.A.B., J.S.) and Department of Vascular Biology (L.K.C.), La Jolla, Calif.
Correspondence to Linda K. Curtiss, PhD, The Scripps Research Institute, IMM-17, 10666 N Torrey Pines Rd, La Jolla, CA 92037. E-mail lcurtiss@scripps.edu.
Bone marrowderived macrophages and lymphocytes express LDL receptors (LDL-R), which allow these cells to take up cholesterol-rich lipoproteins. Although these cells are ubiquitously distributed in the body, it is not known whether they influence plasma cholesterol. Macrophages and T lymphocytes also are found in atherosclerotic lesions, but it is not known whether their LDL-R expression plays a role in atherosclerosis. To address these questions, we subjected LDL-R -/- mice to total body irradiation to eliminate their endogenous bone marrowderived cells and repopulated them with either LDL-Rexpressing wild-type bone marrow (treated mice) or LDL-R -/- bone marrow (control mice). Thus, the only difference between the two groups of mice was the ability of the bone marrowderived cells to express the LDL-R in the treated mice. Plasma cholesterol levels were similar in the two groups of mice at 8 and 16 weeks after transplantation. Chromatographic separation of the lipoproteins revealed similar lipoprotein cholesterol distributions. Although the extent of lesion area in the aortic valves of the high-fat-dietfed mice was more severe than that in the chow-fed mice, lesions appeared similar between control and treated mice given either chow or high-fat diet. Abundant LDL-R expression was detected in the lesions of treated mice, whereas the lesions of control mice showed no LDL-R expression, indicating that donor-derived leukocytes had migrated into the lesions of the recipient mice. Thus, bone marrow transplantation can be used as a tool to replace the endogenous bone marrowderived cells in the artery wall with those of the donor origin.
Key Words: mouse model bone marrow transplantation gene transfer immunohistochemistry atherogenic diet
This article has been cited by other articles:
![]() |
A. Alipour, A. J.H. H.M van Oostrom, A. Izraeljan, C. Verseyden, J. M. Collins, K. N. Frayn, T. W.M. Plokker, J. W. F. Elte, and M. Castro Cabezas Leukocyte Activation by Triglyceride-Rich Lipoproteins Arterioscler. Thromb. Vasc. Biol., April 1, 2008; 28(4): 792 - 797. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Overton, P. G. Yancey, A. S. Major, M. F. Linton, and S. Fazio Deletion of Macrophage LDL Receptor-Related Protein Increases Atherogenesis in the Mouse Circ. Res., March 16, 2007; 100(5): 670 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Cassis, D. L. Rateri, H. Lu, and A. Daugherty Bone Marrow Transplantation Reveals That Recipient AT1a Receptors Are Required to Initiate Angiotensin II-Induced Atherosclerosis and Aneurysms Arterioscler. Thromb. Vasc. Biol., February 1, 2007; 27(2): 380 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Baldan, L. Pei, R. Lee, P. Tarr, R. K. Tangirala, M. M. Weinstein, J. Frank, A. C. Li, P. Tontonoz, and P. A. Edwards Impaired Development of Atherosclerosis in Hyperlipidemic Ldlr-/- and ApoE-/- Mice Transplanted With Abcg1-/- Bone Marrow Arterioscler. Thromb. Vasc. Biol., October 1, 2006; 26(10): 2301 - 2307. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Tilley, B. Pedersen, R. Pawlinski, Y. Sato, J. H. Erlich, Y. Shen, S. Day, Y. Huang, D. T. Eitzman, W. A. Boisvert, et al. Atherosclerosis in Mice Is Not Affected by a Reduction in Tissue Factor Expression Arterioscler. Thromb. Vasc. Biol., March 1, 2006; 26(3): 555 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Daugherty, N. R. Webb, D. L. Rateri, and V. L. King Thematic review series: The Immune System and Atherogenesis. Cytokine regulation of macrophage functions in atherogenesis J. Lipid Res., September 1, 2005; 46(9): 1812 - 1822. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liu, D. P. Thewke, Y. R. Su, M. F. Linton, S. Fazio, and M. S. Sinensky Reduced Macrophage Apoptosis Is Associated With Accelerated Atherosclerosis in Low-Density Lipoprotein Receptor-Null Mice Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 174 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nakai, K. Iwabuchi, S. Fujii, N. Ishimori, N. Dashtsoodol, K. Watano, T. Mishima, C. Iwabuchi, S. Tanaka, J. S. Bezbradica, et al. Natural killer T cells accelerate atherogenesis in mice Blood, October 1, 2004; 104(7): 2051 - 2059. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Covey, M. Krieger, W. Wang, M. Penman, and B. L. Trigatti Scavenger Receptor Class B Type I-Mediated Protection Against Atherosclerosis in LDL Receptor-Negative Mice Involves Its Expression in Bone Marrow-Derived Cells Arterioscler. Thromb. Vasc. Biol., September 1, 2003; 23(9): 1589 - 1594. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Merched, E. Williams, and L. Chan Macrophage-Specific p53 Expression Plays a Crucial Role in Atherosclerosis Development and Plaque Remodeling Arterioscler. Thromb. Vasc. Biol., September 1, 2003; 23(9): 1608 - 1614. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Whitman, D. L. Rateri, S. J. Szilvassy, J. A. Cornicelli, and A. Daugherty Macrophage-specific expression of class A scavenger receptors in LDL receptor-/- mice decreases atherosclerosis and changes spleen morphology J. Lipid Res., August 1, 2002; 43(8): 1201 - 1208. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Pinderski, M. P. Fischbein, G. Subbanagounder, M. C. Fishbein, N. Kubo, H. Cheroutre, L. K. Curtiss, J. A. Berliner, and W. A. Boisvert Overexpression of Interleukin-10 by Activated T Lymphocytes Inhibits Atherosclerosis in LDL Receptor-Deficient Mice by Altering Lymphocyte and Macrophage Phenotypes Circ. Res., May 31, 2002; 90(10): 1064 - 1071. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. King, S. J. Szilvassy, and A. Daugherty Interleukin-4 Deficiency Decreases Atherosclerotic Lesion Formation in a Site-Specific Manner in Female LDL Receptor-/- Mice Arterioscler. Thromb. Vasc. Biol., March 1, 2002; 22(3): 456 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. Schiller, N. Kubo, W. A. Boisvert, and L. K. Curtiss Effect of {gamma}-Irradiation and Bone Marrow Transplantation on Atherosclerosis in LDL Receptor-Deficient Mice Arterioscler. Thromb. Vasc. Biol., October 1, 2001; 21(10): 1674 - 1680. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Herijgers, M. Van Eck, P. H. E. Groot, P. M. Hoogerbrugge, and T. J. C. Van Berkel Low Density Lipoprotein Receptor of Macrophages Facilitates Atherosclerotic Lesion Formation in C57Bl/6 Mice Arterioscler. Thromb. Vasc. Biol., August 1, 2000; 20(8): 1961 - 1967. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kubo, W. A. Boisvert, C. M. Ballantyne, and L. K. Curtiss Leukocyte CD11b expression is not essential for the development of atherosclerosis in mice J. Lipid Res., July 1, 2000; 41(7): 1060 - 1066. [Abstract] [Full Text] |
||||
![]() |
M. Rudling, M. Gafvels, P. Parini, G. Gahrton, and B. Angelin Lipoprotein Receptors in Acute Myelogenous Leukemia : Failure to Detect Increased Low-Density Lipoprotein (LDL)Receptor Numbers in Cell Membranes despite Increased Cellular LDLDegradation Am. J. Pathol., December 1, 1998; 153(6): 1923 - 1935. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Herijgers, M. Van Eck, P. H. E. Groot, P. M. Hoogerbrugge, and T. J. C. Van Berkel Effect of Bone Marrow Transplantation on Lipoprotein Metabolism and Atherosclerosis in LDL Receptor–Knockout Mice Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 1995 - 2003. [Abstract] [Full Text] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |